|
|
|
Insider
Information: |
Bozigian Haig P. |
Relationship: |
Chief Development Offi... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
157,651 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,978,619 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
157,651 |
|
|
Total
Value |
$20,978,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2014-12-12 |
4 |
AS |
$22.50 |
$224,955 |
D/D |
(9,998) |
78,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-10 |
4 |
OE |
$32.99 |
$234,889 |
D/D |
7,120 |
149,096 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2013-06-20 |
4 |
AS |
$12.30 |
$255,651 |
D/D |
(20,769) |
76,954 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2020-08-05 |
4 |
AS |
$118.89 |
$268,324 |
D/D |
(2,257) |
150,663 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-06-03 |
4 |
AS |
$85.51 |
$293,719 |
D/D |
(3,435) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-13 |
4 |
OE |
$8.66 |
$299,177 |
D/D |
34,547 |
176,523 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2013-06-21 |
4 |
AS |
$12.50 |
$303,375 |
D/D |
(23,962) |
76,954 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-08 |
4 |
OE |
$8.65 |
$314,147 |
D/D |
36,295 |
152,791 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2017-08-04 |
4 |
OE |
$5.76 |
$317,200 |
D/D |
45,000 |
149,601 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2014-12-17 |
4 |
AS |
$22.51 |
$337,695 |
D/D |
(15,002) |
78,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-06 |
4 |
OE |
$35.99 |
$339,026 |
D/D |
9,420 |
145,417 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-24 |
4 |
OE |
$19.59 |
$342,551 |
D/D |
17,486 |
159,462 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2017-09-06 |
4 |
OE |
$8.65 |
$350,138 |
D/D |
26,250 |
140,851 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-06-13 |
4 |
OE |
$19.59 |
$357,469 |
D/D |
17,268 |
143,408 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-07 |
4 |
OE |
$5.76 |
$371,105 |
D/D |
29,399 |
151,043 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-31 |
4 |
OE |
$19.59 |
$378,028 |
D/D |
19,297 |
161,273 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2014-01-07 |
4 |
AS |
$17.50 |
$437,500 |
D/D |
(25,000) |
76,954 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2021-02-08 |
4 |
AS |
$116.78 |
$448,749 |
D/D |
(3,842) |
157,651 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
|
2014-01-17 |
4 |
AS |
$20.00 |
$500,000 |
D/D |
(25,000) |
78,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-10 |
4 |
AS |
$87.63 |
$623,958 |
D/D |
(7,120) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
129,601 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2015-01-08 |
4 |
AS |
$27.11 |
$817,200 |
D/D |
(30,000) |
78,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-03-05 |
4 |
OE |
$5.76 |
$976,703 |
D/D |
75,873 |
150,396 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-15 |
4 |
OE |
$32.99 |
$1,012,133 |
D/D |
30,680 |
172,656 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-06 |
4 |
AS |
$110.10 |
$1,037,167 |
D/D |
(9,420) |
135,997 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|